IL9 and neoplasm: For example, in solid tumors such as non-small cell lung cancer and breast cancer, IL-9 can induce the immunosuppressive effects of Treg cells and mast cells in the TME, promote angiogenesis, or upregulate the expression of PD-1 molecules on cytotoxic T lymphocytes to enhance tumor immune escape (18, 19).